Arum Therapeutics
PrivateLast Round
Series A
Apr 19, 2021
Total Funding Raised
$8.79M
Company Overview
Arum Therapeutics is a biotechnology company that develops novel anticancer agents and therapeutics for rare diseases by utilizing a synthetic lethality platform targeting DNA damage response mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arum Therapeutics Comparables
Compare Arum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FoRx Therapeutics | 82% | |
| Nanyang Biologics | 78% | |
| Curovir AB | 77% |
Arum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 19, 2021 | ||||
| Seed | Apr 1, 2020 |
Arum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KDB Capital Corp | Series A |
| DAYLI Partners | Seed, Series A |
| SBI Investment Korea | Series A |
| Partners Investment | Series A |
| AJU IB Investment | Series A |
Arum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arum Therapeutics's valuation, stock price, and market status.
Is Arum Therapeutics a public or private company?
Arum Therapeutics is a private company.
What is the current stock price of Arum Therapeutics?
Arum Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Arum Therapeutics worth (valuation)?
Valuation information for Arum Therapeutics is not publicly available.
Can I buy Arum Therapeutics stock?
Arum Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Arum Therapeutics's last funding round?
Arum Therapeutics's most recent funding round was Series A on April 19, 2021.
Who are the main investors in Arum Therapeutics?
Key investors in Arum Therapeutics include DAYLI Partners.
Will Arum Therapeutics IPO soon?
No public IPO plans have been announced for Arum Therapeutics.
How can I track Arum Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arum Therapeutics's secondary market activity and sign up for updates.